The global demand for Preclinical Imaging Market is presumed to reach the market size of nearly USD 5.9 MN by 2028 from USD 4.25 MN in 2021 with a CAGR of 4.8% under the study period 2022 - 2028.
Preclinical imaging has become an important technique for biological discoveries in the last few years. This imaging uses techniques to visualize biological processes in model organisms like mice and rats. Preclinical imaging is known for visualising living animals for research purposes such as drug development. It is used to monitor treatment regime responses and can provide early indications of efficacy. Preclinical imaging is a multidisciplinary field of molecular biology, chemistry, computer science, engineering, and medicine.
Market Dynamics
The market's growth is primarily driven by the increasing number of investments and funding in research and development and the constant pace of technological advancements. The surging demand for non-invasive small animal imaging techniques is the most significant factor driving the growth of this market. Moreover, the growing demand from veterinary hospitals and educational institutions helps to cushion market growth over the forecast period. The surge in sophisticated diagnostic technologies and increased early diagnosis are expected to accelerate the global preclinical imaging market. Furthermore, the huge investments to spread awareness about using preclinical devices are also expected to fuel market growth. On the other hand, the high installation and operational costs are expected to obstruct market growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of preclinical imaging. The growth and trends of preclinical imaging industry provide a holistic approach to this study.
Market Segmentation
This section of the preclinical imaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- CT Imaging
- MRI Imaging
- PET/SPECT Imaging
- Multi-Modal Imaging
- Optical Imaging
- Ultrasound Imaging
- Photoacoustic Imaging
- Reagents
- Services
By Application
- Research And Development
- Drug Discovery
By End Use
- Biotech Companies
- Pharmaceutical Companies
- Research Institutes
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Preclinical Imaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Preclinical Imaging Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the preclinical imaging market include Bruker Corporation, Siemens A.G., General Electric(GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics Inc. (Fujifilm) Inc., Mediso Ltd., Agilent Technologies, MILabs B.V., MR Solutions, Molecubes. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
